Collegium Pharmaceutical (COLL) FCF Margin (2016 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly FCF Margin of 29.41% for Q1 2026, down 131.0% year-over-year from 94.86% in Q1 2025, and down 51.19% quarter-over-quarter from 60.25% in Q4 2025.
Collegium Pharmaceutical (COLL) FCF Margin (2016 - 2026) Analysis & Trends
Collegium Pharmaceutical's FCF Margin history runs 11 years deep, the most recent figure standing at 29.41% for Q1 2026.
- In Q1 2026, FCF Margin fell 131.0% year-over-year to 29.41%; the TTM figure through Mar 2026 stood at 41.6% (up 349.0% YoY), while the FY2025 annual figure was 42.15%, up 972.0% from the prior year.
- FCF Margin for Q1 2026 stood at 29.41%, down from 60.25% in the prior quarter.
- The five-year high for FCF Margin was 229.71% in Q4 2024, with the low at 30.36% in Q1 2022.
- The 5-year median for FCF Margin is 38.5% (2025), against an average of 46.25%.
- The sharpest annual moves came in 2024 and 2025: FCF Margin jumped 18084 bps in 2024, then sank 16946 bps in 2025.
- Collegium Pharmaceutical's FCF Margin stood at 46.49% in 2022, then increased by 5 bps to 48.87% in 2023, then soared by 370 bps to 229.71% in 2024, then tumbled by 74 bps to 60.25% in 2025, then sank by 51 bps to 29.41% in 2026.
- Business Quant data shows COLL's FCF Margin at 29.41% in Q1 2026, 60.25% in Q4 2025, and 37.38% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Collegium Pharmaceutical | 889.49 Mn | 740.17 Mn | 110.29 Mn | 35.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 548.62% |
| Mar 31, 2026 | 29.41% |
| Dec 31, 2025 | 60.25% |
| Sep 30, 2025 | 37.38% |
| Jun 30, 2025 | 38.50% |
| Mar 31, 2025 | 30.72% |
| Dec 31, 2024 | 229.71% |
| Sep 30, 2024 | -6.20% |
| Jun 30, 2024 | 46.65% |
| Mar 31, 2024 | 42.35% |
| Dec 31, 2023 | 48.87% |
| Sep 30, 2023 | 54.10% |
| Jun 30, 2023 | 73.53% |
| Mar 31, 2023 | 18.99% |
| Dec 31, 2022 | 46.49% |
| Sep 30, 2022 | 33.58% |
| Jun 30, 2022 | 32.37% |
| Mar 31, 2022 | -30.36% |
| Dec 31, 2021 | 93.10% |
| Sep 30, 2021 | 21.53% |